The partners aim to streamline clinical trials by automating data transfer from electronic health records to trial databases to reduce administrative burdens and accelerate research.
The company will use the funds to scale its technology, expand into new biomarker applications, and advance real-time hydration and metabolic health monitoring.
The collaboration will provide funding, resources and market access to startups developing healthcare technologies expanding into the United States market from the U.K.
The partnership highlights the broader trend of AI-driven innovation in drug discovery and precision medicine.
The acquisition allows Medbridge to expand its AI-enabled body movement analysis offerings for rehabilitation patients.
Through the collaboration, adult men will now have access to Tolmar's testosterone replacement therapy, Jatenzo, via UpScriptHealth's telehealth platform.
The cancer care center will work with AI-enabled spatial computing company Proto Hologram to provide holographic doctor/oncology patient visits.
The organizations will use drones to transport blood samples between Guy’s Hospital and the lab at St. Thomas’ Hospital in London.
The collaboration combines the companies' menopause and virtual care offerings to broaden access to care services for women navigating symptoms of menopause.
